Active Ingredient History

NOW
  • Now
Atipamezole, is a synthetic α2 adrenergic receptor antagonist indicated for the reversal of the sedative and analgesic effects of dexmedetomidine and medetomidine in dogs. Its reversal effect works by competing with the sedative for α2-adrenergic receptors and displacing them. It is mainly used in veterinary medicine, and while it is only licensed for dogs and for intramuscular use, it has been used intravenously, as well as in cats and other animals(intravenous use in cats and dogs is not recommended due to the potential for cardiovascular collapse. This occurs due to profound hypotension caused by reversal of the alpha 1 effects while the reflex bradycardia is still in effect.). There is a low rate of side effects, largely due to atipamezole's high specificity for the α2-adrenergic receptor. Atipamezole has a very quick onset, usually waking an animal up within 5 to 10 minutes.   Wikipedia

  • SMILES: CCC1(Cc2ccccc2C1)c3cnc[nH]3
  • InChIKey: HSWPZIDYAHLZDD-UHFFFAOYSA-N
  • Mol. Mass: 212.3
  • ALogP: 2.86
  • ChEMBL Molecule:
More Chemistry
1h-imidazole, 4-(2-ethyl-2,3-dihydro-1h-inden-2-yl)- | antipamezole | antisedan | atipamezole | mpv 1248 | mpv-1248

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue